Show simple item record

dc.contributor.authorGreene, Brittani R.
dc.date.accessioned2018-03-28T18:51:03Z
dc.date.accessioned2020-06-22T14:35:10Z
dc.date.available2018-03-28T18:51:03Z
dc.date.available2020-06-22T14:35:10Z
dc.date.issued2017
dc.identifier.urihttp://hdl.handle.net/20.500.12648/1069
dc.descriptionDysphagia can impact people of all ages because it co-occurs with numerous disorders and health problems. Dysphagia effects over nine million people a year and mainly targets adults over the age of sixty. One cause of dysphagia may be cricopharyngeal dysfunction. This review looks at the use of Botulinum toxin type A (BtxA) injections as a way to relax the cricopharyngeal muscle to help with upper esophageal dysfunction. The literature agreed that botulinum toxin injections are a safe and effective treatment that improves swallowing function for most patients. Patients who did not benefit from BtxA may have had other complications, or a possible diffusion of the BtxA into the surrounding muscle.en_US
dc.language.isoen_USen_US
dc.subjectcricopharyngealen_US
dc.subjectbotulinum toxinen_US
dc.subjectupper esophageal sphincteren_US
dc.titleBotulinum Toxin Type A Injections into the Cricopharyngeal Muscle to Treat Upper Esophageal Dysfunctionen_US
dc.typePresentationen_US
refterms.dateFOA2020-06-22T14:35:10Z
dc.description.institutionSUNY Plattsburgh


Files in this item

Thumbnail
Name:
fulltext.pdf
Size:
724.4Kb
Format:
PDF
Description:
Poster

This item appears in the following Collection(s)

Show simple item record